Last updated: December 5, 2022
Sponsor: Zhang Xiaofeng,MD
Overall Status: Completed
Phase
N/A
Condition
Colorectal Cancer
Colon Cancer
Treatment
N/AClinical Study ID
NCT05648318
20211206301
Ages 18-70 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients over 18 years old and with low-risk were eligible. Patients were consideredas low risk if they did not meet any of the following risk factors: age>70 years old,body mass index (BMI)>25Kg/m2, constipation, Parkinson's disease, diabetes, history ofstroke or spinal cord injury, use of tricyclic antidepressant or narcotics.
Exclusion
Exclusion Criteria:
- (1) history of colorectal resection; (2) Known or suspected colonic stricture orobstructing tumor; (3) Known or suspected colonic perforation; (4) toxic colitis ormegacolon; (5) use of prokinetic agents or purgatives within 7 days; (6) hemodynamicinstability; (7) pregnancy or lactation; (8) inability to provide informed consent.
Study Design
Total Participants: 255
Study Start date:
January 08, 2022
Estimated Completion Date:
September 12, 2022
Connect with a study center
Hangzhou first people's Hospital
Hangzhou, Zhejiang 310000
ChinaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.